ECOR

$0.00

(

0.00%

)
Quote details

stock

Electrocore LLC

NASDAQ | ECOR

5.10

USD

$0.00

(

0.00%

)

At Close (As of Nov 18, 2025)

$42.06M

Market Cap

-

P/E Ratio

-1.71

EPS

$19.49

52 Week High

$4.16

52 Week Low

HEALTHCARE

Sector

ECOR Chart

Recent Chart
Price Action

ECOR Technicals

Tags:

ECOR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $21M
Total Revenue $25M
Cost Of Revenue $3.8M
Costof Goods And Services Sold $3.8M
Operating Income -$12M
Selling General And Administrative $31M
Research And Development $2.4M
Operating Expenses $34M
Investment Income Net -
Net Interest Income $572K
Interest Income $572K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$12M
Income Tax Expense -$93K
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$11M
Net Income -$12M

Revenue & Profitability

Earnings Performance

ECOR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $20M
Total Current Assets $16M
Cash And Cash Equivalents At Carrying Value $3.5M
Cash And Short Term Investments $3.5M
Inventory $1.7M
Current Net Receivables $1.4M
Total Non Current Assets $4.2M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $8.5M
Other Current Assets $1.3M
Other Non Current Assets -
Total Liabilities $13M
Total Current Liabilities $9.2M
Current Accounts Payable $1.8M
Deferred Revenue -
Current Debt -
Short Term Debt $361K
Total Non Current Liabilities $3.8M
Capital Lease Obligations $4.1M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $4.1M
Other Current Liabilities $6.5M
Other Non Current Liabilities -
Total Shareholder Equity $7.5M
Treasury Stock -
Retained Earnings -$177M
Common Stock $7K
Common Stock Shares Outstanding $7.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$6.9M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.3M
Capital Expenditures $0
Change In Receivables -
Change In Inventory $713K
Profit Loss -
Cashflow From Investment -$8.5M
Cashflow From Financing $8.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$12M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $21M
Total Revenue $25M
Cost Of Revenue $3.8M
Costof Goods And Services Sold $3.8M
Operating Income -$12M
Selling General And Administrative $31M
Research And Development $2.4M
Operating Expenses $34M
Investment Income Net -
Net Interest Income $572K
Interest Income $572K
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.3M
Income Before Tax -$12M
Income Tax Expense -$93K
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit -$12M
Ebitda -$11M
Net Income -$12M

ECOR News

ECOR Profile

Electrocore LLC Profile

Sector: HEALTHCARE

Industry: MEDICAL DEVICES

Electrocore, Inc. is a commercial-stage medical device company based in Rockaway, New Jersey, specializing in non-invasive vagus nerve stimulation (nVNS) therapies aimed at treating neurological disorders such as chronic pain, migraine, and epilepsy. By leveraging its innovative product portfolio and strong clinical evidence, Electrocore is positioned as a leader in the neuromodulation market, demonstrating a robust commitment to improving patient outcomes. The company's focus on advancing non-invasive therapeutic solutions highlights its potential to significantly enhance the quality of life for patients grappling with debilitating neurological conditions.

LPTX
+368.57%
$2.05
CANF
+9.11%
$0.39
ASBP
+19.05%
$0.10
NVDA
-1.87%
$186.60
WTO
-12.00%
$0.02
LOBO
+31.04%
$0.51
ONDS
+18.94%
$7.44
CHR
+0.63%
$0.04
PLUG
+8.15%
$2.25
OLMA
+146.12%
$20.97
ASST
+7.40%
$1.11
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DFLI
-1.27%
$0.80
TSLA
-0.89%
$405.25
ADAP
-15.14%
$0.05
SOFI
-0.78%
$26.82
QUBT
+8.14%
$12.43
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ETHD
-8.69%
$5.19
WBD
-1.25%
$22.74
SNAP
+1.89%
$8.33
INTC
-0.30%
$34.60
PLTR
-0.25%
$170.81
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
CAN
+21.91%
$1.03
DNN
+0.22%
$2.39
WULF
+10.54%
$12.21
NIO
-2.79%
$5.91
BMNR
+6.13%
$32.84
BITF
+0.82%
$2.69
AMZN
-3.70%
$224.24
ACHR
+4.17%
$7.73
PFE
+1.25%
$25.39
F
+1.01%
$13.01
AMD
-2.59%
$234.28
KXIN
+2.81%
$0.29
GOOGL
+0.54%
$286.56
NOK
-0.22%
$6.64
TLRY
+0.48%
$1.03
BURU
-1.85%
$0.21
CIFR
+3.72%
$14.88
WLGS
-5.57%
$0.04
GPUS
-2.81%
$0.23
MTSR
-0.35%
$70.50
TWOH
+4.16%
$0.00
ONFO
+10.44%
$0.93
LFS
+81.34%
$6.99
MARA
+3.38%
$11.90
AAL
+0.52%
$12.40
APLT
+4.78%
$0.29
RUBI
+1.27%
$0.17
ABEV
+0.01%
$2.54
BYND
0.00%
$1.04
CGTL
-14.51%
$0.69
PLTD
+0.00%
$6.96
KVUE
-0.52%
$16.15
IREN
+5.20%
$49.88
AFMD
-34.94%
$0.18
CRWV
+2.34%
$77.09
RGTI
+2.36%
$25.27
GRAB
+0.09%
$5.33
NFLX
+3.86%
$114.55
MU
-3.36%
$233.80
RIVN
+0.92%
$15.00
BMNU
+12.37%
$8.81
GLMD
-1.92%
$1.02
AAPL
+0.45%
$268.67
HOOD
+0.50%
$116.55
RIG
+0.32%
$4.09
DVLT
-5.36%
$1.76
KDLY
-9.91%
$0.55
MSFT
-2.92%
$492.64
GRYP
-10.38%
$1.38
SOUN
+1.53%
$11.60
T
+0.88%
$25.69
BTG
-0.62%
$3.96
MODV
-25.22%
$0.43
MRK
+4.23%
$96.79
IONZ
-6.41%
$4.71
PLTZ
-0.63%
$7.05
AGNC
-0.49%
$10.10
GGB
-1.41%
$3.49
BBD
-0.13%
$3.61
QS
+3.62%
$13.42
VALE
+0.61%
$12.24
CSX
-2.55%
$34.01
QBTS
+1.27%
$23.12
GOOG
+1.05%
$288.62
BTBT
+5.00%
$2.41
APLD
+0.37%
$23.02
NBIS
+7.38%
$92.33
NKE
-1.97%
$62.90
RXRX
+2.40%
$4.21
CLF
+2.37%
$11.23
HIMS
+1.12%
$35.98
EPSM
+53.61%
$2.18
LPTX
+368.57%
$2.05
CANF
+9.11%
$0.39
ASBP
+19.05%
$0.10
NVDA
-1.87%
$186.60
WTO
-12.00%
$0.02
LOBO
+31.04%
$0.51
ONDS
+18.94%
$7.44
CHR
+0.63%
$0.04
PLUG
+8.15%
$2.25
OLMA
+146.12%
$20.97
ASST
+7.40%
$1.11
VHAI
-25.00%
$0.00
AXDX
-61.36%
$0.03
DFLI
-1.27%
$0.80
TSLA
-0.89%
$405.25
ADAP
-15.14%
$0.05
SOFI
-0.78%
$26.82
QUBT
+8.14%
$12.43
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ETHD
-8.69%
$5.19
WBD
-1.25%
$22.74
SNAP
+1.89%
$8.33
INTC
-0.30%
$34.60
PLTR
-0.25%
$170.81
XPEV
-10.31%
$22.43
SRM
+53.27%
$10.30
CAN
+21.91%
$1.03
DNN
+0.22%
$2.39
WULF
+10.54%
$12.21
NIO
-2.79%
$5.91
BMNR
+6.13%
$32.84
BITF
+0.82%
$2.69
AMZN
-3.70%
$224.24
ACHR
+4.17%
$7.73
PFE
+1.25%
$25.39
F
+1.01%
$13.01
AMD
-2.59%
$234.28
KXIN
+2.81%
$0.29
GOOGL
+0.54%
$286.56
NOK
-0.22%
$6.64
TLRY
+0.48%
$1.03
BURU
-1.85%
$0.21
CIFR
+3.72%
$14.88
WLGS
-5.57%
$0.04
GPUS
-2.81%
$0.23
MTSR
-0.35%
$70.50
TWOH
+4.16%
$0.00
ONFO
+10.44%
$0.93
LFS
+81.34%
$6.99
MARA
+3.38%
$11.90
AAL
+0.52%
$12.40
APLT
+4.78%
$0.29
RUBI
+1.27%
$0.17
ABEV
+0.01%
$2.54
BYND
0.00%
$1.04
CGTL
-14.51%
$0.69
PLTD
+0.00%
$6.96
KVUE
-0.52%
$16.15
IREN
+5.20%
$49.88
AFMD
-34.94%
$0.18
CRWV
+2.34%
$77.09
RGTI
+2.36%
$25.27
GRAB
+0.09%
$5.33
NFLX
+3.86%
$114.55
MU
-3.36%
$233.80
RIVN
+0.92%
$15.00
BMNU
+12.37%
$8.81
GLMD
-1.92%
$1.02
AAPL
+0.45%
$268.67
HOOD
+0.50%
$116.55
RIG
+0.32%
$4.09
DVLT
-5.36%
$1.76
KDLY
-9.91%
$0.55
MSFT
-2.92%
$492.64
GRYP
-10.38%
$1.38
SOUN
+1.53%
$11.60
T
+0.88%
$25.69
BTG
-0.62%
$3.96
MODV
-25.22%
$0.43
MRK
+4.23%
$96.79
IONZ
-6.41%
$4.71
PLTZ
-0.63%
$7.05
AGNC
-0.49%
$10.10
GGB
-1.41%
$3.49
BBD
-0.13%
$3.61
QS
+3.62%
$13.42
VALE
+0.61%
$12.24
CSX
-2.55%
$34.01
QBTS
+1.27%
$23.12
GOOG
+1.05%
$288.62
BTBT
+5.00%
$2.41
APLD
+0.37%
$23.02
NBIS
+7.38%
$92.33
NKE
-1.97%
$62.90
RXRX
+2.40%
$4.21
CLF
+2.37%
$11.23
HIMS
+1.12%
$35.98
EPSM
+53.61%
$2.18

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.